India Firm Introduces Generic Breast Cancer Drug
- By BSTQ Staff
Panacea Biotec, an India-based biotechnology firm, has introduced a generic breast cancer treatment medicine called PacliALL. Developed at the Global Research and Development Center in Navi Mumbai, PacliALL is meant to be used as a chemotherapeutic agent for the treatment of breast cancer, offering patients shorter infusion time and eliminating the need for premedication. According to the company, the drug will be made available at a price that will be nearly 50 percent lower than the competitive products in the domestic and global markets.